Evidence map›Paper›PMID 31463646›Full record

ArticleInflammation2019

Upregulated MiR-9-5p Protects Against Inflammatory Response in Rats with Deep Vein Thrombosis via Inhibition of NF-κB p50.

Minghui Ou, Yunfeng Zhang, Shichao Cui, Shibo Zhao, Jie Tu

RetractedAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in Inflammation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. microRNAs involved in psoriasis and cardiovascular diseases.Vascular biology (Bristol, England) · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Minghui OuDepartment of Vascular Surgery, Qingdao Municipal Hospital, Qingdao, 266011, People's Republic of China.
Yunfeng ZhangDepartment of Orthopedics, Qingdao Municipal Hospital, Qingdao, 266011, People's Republic of China.
Shichao CuiDepartment of Vascular Surgery, Qingdao Municipal Hospital, Qingdao, 266011, People's Republic of China.
Shibo ZhaoDepartment of Vascular Surgery, Qingdao Municipal Hospital, Qingdao, 266011, People's Republic of China.
Jie TuScience and Education Department, Qingdao Municipal Hospital, No. 1, Jiaozhou Road Shandong Province, Qingdao, 266011, People's Republic of China. DrTujie_TJ@163.com.
Qingdao Municipal Hospital · CNQingdao University · CN

Funding

General Program of National Natural Science Foundation 81871187Natural Science Foundation Project of Ningxia Hui Autonomous Region NZ17195Regional Projects of National Natural Science Foundation 81460239
6 · The paper itself

Abstract

Recently, microRNAs (miRNAs) have been demonstrated to play important roles in the cardiovascular system, including heart, blood vessels, plasma, and vascular diseases. Deep vein thrombosis (DVT) refers to the formation of blood clot in the deep veins of the human body and is a common peripheral vascular disease. Herein, we explored the mechanism of miR-9-5p in DVT through nuclear factor-κB (NF-κB). The expression of miR-9-5p in DVT rats was measured through the establishment of DVT rat models, followed by the alteration of miR-9-5p and NF-κB p50 in rats through the injection of constructed lentiviral vectors so as to explore the role of miR-9-5p and NF-κB p50 expression in rats. Next, the expression of NF-κB p50 and levels of inflammation-related factors plasminogen activator inhibitor-1 (PAI-1), interleukin-6 (IL-6), tumor necrosis factor α (TNF-α), and interleukin-8 (IL-8) were measured after the injection with lentiviral vectors, followed by the assessment of platelet aggregation and TXB2 content. MiR-9-5p was found to be downregulated in DVT rats. Through dual luciferase reporter gene assay, NF-κB p50 was verified as the target gene of miR-9-5p and miR-9-5p could negatively regulate NF-κB p50. MiR-9-5p over-expression decreased the levels of PAI-1, TNF-α, IL-6, and IL-8 and platelet aggregation as well as TXB2 content, thus inhibiting thrombosis. Meanwhile, over-expressed NF-κB p50 could reverse the anti-inflammatory or anti-thrombotic effect of miR-9-5p. In summary, miR-9-5p over-expression can suppress the NF-κB signaling pathway through p50 downregulation, thus alleviating inflammation and thrombosis in DVT rats. MiR-9-5p could serve as a potential therapeutic target for DVT.

Indexed as

AnimalsGene Expression RegulationInflammationInterleukin-6Interleukin-8MicroRNAsNF-kappa B p50 SubunitPlasminogen Activator Inhibitor 1Platelet AggregationProtective AgentsRatsThromboxane B2Tumor Necrosis Factor-alphaVenous ThrombosisInterleukin-6Interleukin-8MicroRNAsMIRN9 microRNA, ratNF-kappa B p50 SubunitPlasminogen Activator Inhibitor 1Protective AgentsThromboxane B2Tumor Necrosis Factor-alphadeep vein thrombosisinflammatory responseinhibitionmicroRNA-9-5pnuclear factor-κBp50thrombosistranscription factor

Identifiers

PMID31463646
OpenAlexW2970239026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.